Erythromycin Prices

Erythromycin Prices June 2023

The Q2 price of erythromycin in the United States reached 159,264 USD/MT in June 2023. Similarly, in China, the price trend for erythromycin was recorded 148,068 USD/MT in June 2023. Whereas Germany’s erythromycin prices accounted for 165,785 USD/MT in June 2023.

Erythromycin Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Erythromycin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of erythromycin pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of erythromycin at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of erythromycin price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing erythromycin price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Erythromycin Market Analysis  

The global erythromycin market size reached US$ 17.6 Billion in 2023. By 2032, IMARC Group expects the market to hit US$ 28.6 Billion, at an anticipated CAGR of 5.50% during 2023-2032.

• There is an increase in the utilization of erythromycin to treat respiratory tract infections (RTIs) like common cold, laryngitis, pharyngitis or tonsillitis, acute rhinitis, acute rhinosinusitis, acute otitis media, acute bronchitis, bronchiolitis, pneumonia, and tracheitis. People need effective antibiotics for fighting these infections, which is catalyzing the demand for erythromycin in the world.          
• The growing demand for erythromycin on account of the rising geriatric population across the globe is offering a positive market outlook. Elderly people are more vulnerable to bacterial infections because of their weakened immune systems and comorbidities. In addition, common infections among elderly individuals include respiratory tract infections, skin infections, and urinary tract infections, all of which can be effectively treated with erythromycin. The population of people aged 60 years and plus is likely to hit 2.1 Billion in 2050 as stated by the United Nations (UN).
• The erythromycin demand is further impelled by the increasing awareness among individuals and healthcare providers about the diagnosis of bacterial infections. Better diagnostic techniques and the wide access to healthcare facilities are supporting earlier diagnoses and treatment of bacterial infections. Apart from this, public health initiatives that aims to educate populations about the importance of early diagnosis and treatment of infections contribute to an increase in the demand for erythromycin.
• Erythromycin is also becoming increasingly popular as companies are focusing on expanding their product portfolios and geographical presence through mergers and acquisitions (M&As) and partnerships. In addition, manufacturers are introducing new formulations and dosage forms of erythromycin, which are beneficial in enhancing its market accessibility to a larger population worldwide. 
• Erythromycin is widely utilized to treat various skin infections. It is mixed with tretinoin cream or benzoyl peroxide for treating acne problems. It can be applied to the skin or taken by mouth for controlling acne issues among individuals. People are facing these problems due to various factors such as poor dietary habits and environmental stressors.  

Erythromycin News

The report covers the latest developments, updates, and trends impacting the global erythromycin market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in erythromycin production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the erythromycin price trend.

Latest developments in the erythromycin industry:

• 1 September 2023, Zydus Lifesciences Limited received final approval from the United States Food and Drug Administration (USFDA) for erythromycin tablets USP, available in strengths of 250 mg and 500 mg (USRLD: erythromycin Tablets USP, 250 mg and 500 mg).      
   

Product Description  

Erythromycin is a bacteriostatic antibiotic being produced by a strain of Saccharopolyspora erythraea. It belongs to macrolides, a class of antibiotics. Others include, among others, azithromycin, clarithromycin, spiramycin, and others. It works by eliminating the bacteria or stops the growth of the bacteria by reducing the synthesis of vital proteins that are necessary for the bacteria to live. It is administrated through intravenous topical and eye drop preparations. In this regard, erythromycin prevents the elongation of polypeptide chains that are necessary in the bacterial growth and reproduction. It has been effective in a number of skin infections caused by susceptible bacteria such as impetigo and cellulitis. It is used to treat a sexually transmitted infection (STI) that is caused by chlamydia and gonorrhea bacteria.

Regional Coverage

The report provides a detailed analysis of the erythromycin market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the erythromycin price trend. 

Global Erythromycin Price

The report offers a holistic view of the global erythromycin pricing trends in the form of erythromycin price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of erythromycin but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed erythromycin demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Erythromycin Price

European erythromycin prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed erythromycin price information for a comprehensive list of countries.

North America Erythromycin Price

The analysis of erythromycin prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific erythromycin historical data within the United States and Canada can also be provided.

Middle East and Africa Erythromycin Price

The report explores the erythromycin pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on erythromycin prices for countries can also be provided.

Asia Pacific Erythromycin Price

The erythromycin pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This erythromycin price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Erythromycin Price

The analysis of erythromycin prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of erythromycin pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting erythromycin price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The erythromycin price charts ensure our clients remain at the forefront of the industry.